• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195-000
Device Problem Off-Label Use (1494)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/05/2020
Event Type  Injury  
Manufacturer Narrative
The labeling of the extraction reagent clearly defines the materials contained within and the package insert refers to the emergency use authorization restrictions set forth.The safety data sheet was provided to the user.No additional information, evaluation or clarification of data is applicable.The reported event is anticipated in nature and severity for binaxnow covid-19 ag card and captured within the product's risk management file.No additional action is necessary.
 
Event Description
The user reported the accidental use of the binaxnow covid-19 ag extraction reagent instead of the conjunctivitis eyedrop medicine in her baby's eye on (b)(6) 2020.The user stated that her other child administered the binaxnow covid-19 ag reagent to the baby's eye.The user took the baby for an eye exam.The physician performed a litmus test; the ph of the eye was normal.No adverse reaction was observed.The physician did not suggest any treatment for the baby.The baby was reported to be in good health.The user stated that there was no death or serious injury based on the event.Attempts to gain further information were unsuccessful.Due to the reagent ingredients and sensitive nature of the eye, medical opinion determined this event shall be reportable.The user is not a healthcare professional and does not belong to any healthcare/nursing facility.The user reported receiving the test from a family member.Therefore, the customer is not an authorized user of this assay according to the requirements of the package insert.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG CARD
Type of Device
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer (Section G)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
alonna pitreau
10 southgate road
scarborough, ME 04074
2077305750
MDR Report Key10949866
MDR Text Key220687588
Report Number1221359-2020-00413
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA202537
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number195-000
Initial Date Manufacturer Received 11/06/2020
Initial Date FDA Received12/04/2020
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age6 MO
-
-